February 13, 2020 / 12:21 PM / 8 days ago

BRIEF-Karyopharm Therapeutics Posts Q4 Loss Per Share Of $0.76

Feb 13 (Reuters) - Karyopharm Therapeutics Inc:

* KARYOPHARM REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS

* Q4 LOSS PER SHARE $0.76

* Q4 EARNINGS PER SHARE ESTIMATE $-0.67 — REFINITIV IBES DATA

* QTRLY TOTAL REVENUES $18.1 MILLION VERSUS $206,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below